Association of cytokine gene polymorphisms in patients with chronic obstructive pulmonary disease

Oman Medical Journal

Volumn 27, Issue 4, 2012, Pages 285-290

  Shukla, Rajni Kant ^a   Kant, Surya ^a   Bhattacharya, Sandeep ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chronic obstructive pulmonary disease (COPD); Interleukine 1 (IL 1); Tumor necrosis factor alpha (TNF 308)

Indexed keywords

CYTOKINE; GENOMIC DNA;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 84865028237     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2012.71     Document Type: Article

References (42)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995 Nov;152(5 Pt 2):S77-S121.
2. Bascom R. Differential susceptibility to tobacco smoke: possible mechanisms. Pharmacogenetics 1991 Nov;1(2):102-106.
3. Oudijk EJ, Nijhuis EH, Zwank MD, van de Graaf EA, Mager HJ, Coffer PJ, et al. Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils. Thorax 2005 Jul;60(7):538-544.
4. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003 Oct;22(4):672-688.
5. Vamvakopoulos J, Green C, Metcalfe S. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol 2002 Oct;32(10):2988-2996.
6. Witkin SS, Gerber S, Ledger WJ. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002 Jan;34(2):204-209.
7. Kuschner WG, D'Alessandro A, Wong H, Blanc PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996 Oct;9(10):1989-1994.
8. Lundblad LK, Thompson-Figueroa J, Leclair T, Sullivan MJ, Poynter ME, Irvin CG, et al. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med 2005 Jun;171(12):1363-1370.
9. Churg A, Wang RD, Tai H, Wang X, Xie C, Wright JL. Tumor necrosis factoralpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2004 Sep;170(5):492-498.
10. Mueller R, Chanez P, Campbell AM, Bousquet J, Heusser C, Bullock GR. Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir Med 1996 Feb;90(2):79-85.
11. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004 Jul;59(7):574-580.
12. Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001 Feb;163(2):420-422.
13. Chierakul N, Wongwisutikul P, Vejbaesya S, Chotvilaiwan K. Tumor necrosis factor-alpha gene promoter polymorphism is not associated with smokingrelated COPD in Thailand. Respirology 2005 Jan;10(1):36-39.
14. Seifart C, Dempfle A, Plagens A, Seifart U, Clostermann U, Müller B, et al. TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens 2005 Jan;65(1):93-100.
15. Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, et al. Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 1995 Feb;154(3):1432-1439.
16. Lee H, Clark B, Gooi HC, Stoves J, Newstead CG. Influence of recipient and donor IL-1alpha, IL-4, and TNFalpha genotypes on the incidence of acute renal allograft rejection. J Clin Pathol 2004 Jan;57(1):101-103.
17. Hegab AE, Sakamoto T, Saitoh W, Nomura A, Ishii Y, Morishima Y, et al. Polymorphisms of TNFalpha, IL1beta, and IL1RN genes in chronic obstructive pulmonary disease. Biochem Biophys Res Commun 2005 Apr;329(4):1246-1252.
18. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994 Sep;265(5181):2037-2048.
19. Shukla RK, Kant S, Bhattacharya S, Mittal B. Association of genetic polymorphism of GSTT1, GSTM1 and GSTM3 in COPD patients in a north Indian population. COPD 2011 Jun;8(3):167-172.
20. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, Management and prevention of chronic obstructive pulmonary disease. Updated 2009. http://www.goldcopd.com/ Accessed October 2010
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988 Feb;16(3):1215.
22. Rad R, Prinz C, Neu B, Neuhofer M, Zeitner M, Voland P, et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003 Jul;188(2):272-281.
23. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993 May;91(4):403-404.
24. Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001 Sep;29(17):E88-E8.
25. Mout R, Willemze R, Landegent JE. Repeat polymorphisms in the interleukin-4 gene (IL4). Nucleic Acids Res 1991 Jul;19(13):3763.
26. Schneider S. R.D., Excoffier L Arlequin ver. 2.00. Software for population genetics data analysis. Switzerland: Genetics and Biometry Laboratory, University of Geneva 2000.
27. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, Management and prevention of chronic obstructive pulmonary disease. Updated 2009. http://www.goldcopd.com/ Accessed October 2010.
28. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B. Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study. Hum Immunol 2008 Mar;69(3):179-186.
29. Joos L, McIntyre L, Ruan J, Connett JE, Anthonisen NR, Weir TD, et al. Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax 2001 Nov;56(11):863-866.
30. Asada M, Yamaya M, Ebihara S, Yasuda H, Tomita N, Kubo H, et al. Interleukin-1beta gene polymorphisms associated with COPD. Chest 2005 Aug;128(2):1072-1073, author reply 1073.
31. van der Strate BW, Postma DS, Brandsma CA, Melgert BN, Luinge MA, Geerlings M, et al. Cigarette smoke-induced emphysema: A role for the B cell? Am J Respir Crit Care Med 2006 Apr;173(7):751-758.
32. Mund E, Christensson B, Larsson K, Grönneberg R. Sex dependent differences in physiological ageing in the immune system of lower airways in healthy nonsmoking volunteers: study of lymphocyte subsets in bronchoalveolar lavage fluid and blood. Thorax 2001 Jun;56(6):450-455.
33. Camp PG, O'Donnell DE, Postma DS. Chronic obstructive pulmonary disease in men and women: myths and reality. Proc Am Thorac Soc 2009 Sep;6(6):535-538.
34. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998 Aug;28(8):2598-2602.
35. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995 Feb;99(2):303-310.
36. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998 Mar;47(3):195-198.
37. Lynch EA, D.C., Cannon JG Gender differences in IL-lao, IL-13, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion. J Immunol 1994 1994 153, 300-306
38. Kanai T, Fukuda-Miki M, Shimoya K, Azuma C, Hashimoto K, Nobunaga T, et al. Increased interleukin-1 and interleukin-1 receptor antagonist levels in cervical mucus in the ovulatory phase in comparison with the follicular phase. Gynecol Obstet Invest 1997;43(3):166-170.
39. Zhan P, Wang J, Wei SZ, Qian Q, Qiu LX, Yu LK, et al. TNF-308 gene polymorphism is associated with COPD risk among Asians: meta-analysis of data for 6,118 subjects. Mol Biol Rep 2011 Jan;38(1):219-227.
40. Ishii T, Matsuse T, Teramoto S, Matsui H, Miyao M, Hosoi T, et al. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir Med 2000 Sep;94(9):847-851.
41. Le Beau MM, Lemons RS, Espinosa R III, Larson RA, Arai N, Rowley JD. Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Blood 1989 Feb;73(3):647-650.
42. Nakashima H, Miyake K, Inoue Y, Shimizu S, Akahoshi M, Tanaka Y, et al. Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun 2002 Apr;3(2):107-109.